These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 2281582

  • 1. Unequal doses of ioversol versus diatrizoate for urography.
    Baker MK, Kopecky KK, Bogan M, Wass JL.
    Urol Radiol; 1990; 12(3):168-72. PubMed ID: 2281582
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Iohexol for excretory urography: a comparative study.
    Winfield AC, Dray RJ, Kirchner FK, Muhletaler CA, Price RR.
    AJR Am J Roentgenol; 1983 Sep; 141(3):571-3. PubMed ID: 6349311
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Evaluation of clinical tolerability and diagnostic efficacy of ioversol 350 in UIV. A randomized double-blind study of ioversol 350 versus iohexol 350].
    Voegeli E, Woessmer B.
    Ann Radiol (Paris); 1992 Sep; 35(4 Pt 2):293-6. PubMed ID: 1296495
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of iopromide for excretory urography.
    Newhouse JH, Landman J, Lang E, Amis ES, Goldman S, Khazan R, Leder R, Hedgcock M.
    Invest Radiol; 1994 May; 29 Suppl 1():S68-73. PubMed ID: 8071049
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Advantages of nonionic contrast agents in adult urography.
    Dray RJ, Winfield AC, Muhletaler CA, Kirchner FK.
    Urology; 1984 Sep; 24(3):297-9. PubMed ID: 6382739
    [Abstract] [Full Text] [Related]

  • 9. Induction of micronuclei in lymphocytes of patients undergoing excretory urography with ioversol.
    Cochran ST, Norman A.
    Invest Radiol; 1994 Feb; 29(2):210-2. PubMed ID: 8169099
    [Abstract] [Full Text] [Related]

  • 10. Computed body tomography with a new nonionic contrast agent. Comparison of ioversol with sodium/meglumine diatrizoate.
    McClennan BL, Heiken JP, Lee JK, James MA.
    Invest Radiol; 1989 Jun; 24 Suppl 1():S35-8. PubMed ID: 2687193
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of lopamidol and diatrizoate in excretory urography: a double-blind clinical study.
    Cochran ST, Ballard JW, Katzberg RW, Barbaric ZL, Spataro R, Iwamoto K, Lee JJ.
    AJR Am J Roentgenol; 1988 Sep; 151(3):523-7. PubMed ID: 3044040
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A double-blind clinical study comparing the safety, tolerance and efficacy of ioversol and iohexol in intravenous urography.
    Colthurst JR, Chan O, Creagh M, Gordon P, Guy R, Muncey F, Ayers AB.
    Clin Radiol; 1990 Sep; 42(3):174-6. PubMed ID: 2208927
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical profile of ioversol. A metaanalysis of 57 randomized, double-blind clinical trials.
    Floriani I, Ciceri M, Torri V, Tinazzi A, Jahn H, Noseda A.
    Invest Radiol; 1996 Aug; 31(8):479-91. PubMed ID: 8854194
    [Abstract] [Full Text] [Related]

  • 17. Double-blind comparison of iodamide and diatrizoate for excretory urography.
    Rosenfield AT, Putman CE, Ulreich S, Koss N.
    Yale J Biol Med; 1977 Aug; 50(6):631-6. PubMed ID: 345632
    [Abstract] [Full Text] [Related]

  • 18. Ioversol. Double-blind study of a new low osmolar contrast agent for peripheral and visceral arteriography.
    Grassi CJ, Bettmann MA, Finkelstein J, Reagan K.
    Invest Radiol; 1989 Feb; 24(2):133-7. PubMed ID: 2917833
    [Abstract] [Full Text] [Related]

  • 19. High-dose clinical urography with the low-osmolality contrast agent Hexabrix: comparison with a conventional contrast agent.
    Spataro RF, Katzberg RW, Fischer HW, McMannis MJ.
    Radiology; 1987 Jan; 162(1 Pt 1):9-14. PubMed ID: 3538156
    [Abstract] [Full Text] [Related]

  • 20. Iopentol (Imagopaque 300) compared with iohexol (Omnipaque 300) and diatrizoate (Urografin 292) in pediatric urography. A clinical trial assessing adverse events and diagnostic information.
    Lanning P, Brekke O.
    Eur Radiol; 1997 Jan; 7 Suppl 4():S120-2. PubMed ID: 9204352
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.